This article first appeared on GuruFocus .
-
Stand-alone Q4 Revenue:INR599 crores, a growth of 13%.
-
FY26 Stand-alone Revenue:INR1,949 crores, a growth of 20%.
-
Q4 EBITDA:INR191 crores with a margin of 31.9%.
-
FY26 EBITDA:INR564 crores with a margin of 28.9%.
-
Q4 PAT:INR135 crores with a margin of 22.6%.
-
FY26 PAT:INR391 crores with a margin of 20.1%.
-
Consolidated Q4 Revenue:INR599 crores, excluding revenue reversal impact.
-
Consolidated Q4 EBITDA:INR147 crores with a margin of 24.6%.
-
FY26 Consolidated EBITDA:INR527 crores with a margin of 25.2%.
-
Consolidated Q4 PAT:INR91 crores.
-
FY26 Consolidated PAT:INR336 crores, an increase of 6% year-on-year.
-
Q4 FY26 Order Intake:Over INR700 crores.
-
FY26 Order Intake:INR236 crores.
-
Outstanding Order Book as of March 31, 2026:INR4,732 crores.
-
Warning! GuruFocus has detected 2 Warning Signs with NSE:JYOTICNC.
-
Is NSE:JYOTICNC fairly valued? Test your thesis with our free DCF calculator.
Release Date: May 29, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Jyoti CNC Automation Ltd ( NSE:JYOTICNC ) reported a strong stand-alone revenue growth of 20% for FY26, reaching INR1,949 crores.
-
The company achieved a high EBITDA margin of 28.9% for FY26, reflecting strong operational efficiency.
-
The order intake for Q4 FY26 was robust at over INR700 crores, with a diversified order book across sectors such as aerospace, auto, and general engineering.
-
The company is on track to expand its annual capacity to 16,000 machines by Q2 of the current financial year, which is expected to drive future growth.
-
Jyoti CNC Automation Ltd ( NSE:JYOTICNC ) has a healthy and growing order book of INR4,732 crores as of March 31, 2026, indicating strong demand and customer confidence.
Negative Points
-
The company faced capacity constraints, with facilities operating at over 100% utilization during peak demand months, impacting order execution.
-
An ongoing investigation by export control authorities concerning certain export orders at Huron has led to a revenue deferment of INR67 crores.
-
The investigation has impacted consolidated profitability, with Q4 FY26 EBITDA margin dropping to 24.6% due to lower revenue recognition.
-
The company has seen an increase in debt, primarily due to capacity expansion, raising concerns about future financial leverage.
-
Commodity inflation poses a challenge, as the company has a fixed cost base and cannot easily pass on increased costs to customers.
Q & A Highlights
Q: What are the timelines for the investigation to conclude, and why was a revenue deferment chosen over a write-off? A: Parakramsinh Jadeja, Executive Chairman and Managing Director, clarified that the revenue deferment is not a write-off but a postponement due to the lack of export license clearance for certain machines. The investigation's timeline is uncertain, but it has not materially impacted operations. The deferment will be reversed once the export licenses are obtained.
Q: How does the company plan to manage cash flow with the current order book and capacity expansion? A: Parakramsinh Jadeja explained that the company expects improved cash flow due to increased capacity and reduced working capital requirements. The company is optimistic about maintaining a healthy cash flow as new capacity comes online.
Q: With commodity inflation, how does the company manage contract pricing? A: Parakramsinh Jadeja stated that while the company cannot pass increased costs to customers, it is naturally hedged due to its long manufacturing cycle. Price adjustments are made for new orders to compensate for raw material cost increases.
Q: What is the impact of capacity constraints on stand-alone revenue growth? A: Parakramsinh Jadeja confirmed that capacity constraints limited growth, with facilities operating at over 100% utilization. The company plans to expand capacity to meet demand and improve execution.
Q: How will the new capacity impact order inflows and execution timelines? A: Parakramsinh Jadeja mentioned that the company has a healthy order book and expects to ramp up order intake and execution once the new capacity becomes operational in September. The company is already receiving significant orders across sectors.
Q: Is there any risk to the aerospace and defense execution in India due to the investigation? A: Parakramsinh Jadeja assured that the technology for aerospace and defense is developed in-house by Jyoti, and there is no dependency on Huron. The investigation does not affect the execution of Indian orders.
Q: What is the expected utilization of the new capacity, and how will it affect production? A: Parakramsinh Jadeja expects the new capacity to be utilized effectively, with a focus on increasing production across various sectors. The company aims to reach a higher production level by FY27.
Q: How does the company plan to handle the ongoing investigation and its potential impact on Huron's operations? A: Parakramsinh Jadeja stated that the investigation is a standard procedure and has not affected Huron's operations. The company is confident in its ability to navigate the situation and expects no long-term adverse effects.
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
